Signet Financial Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.13M Sell
6,053
-105
-2% -$37.4K 0.24% 115
2025
Q4
$2.02M Sell
6,158
-25
-0.4% -$7.93K 0.23% 119
2025
Q3
$1.74M Sell
6,183
-333
-5% -$96.6K 0.2% 131
2025
Q2
$1.82M Sell
6,516
-394
-6% -$112K 0.23% 125
2025
Q1
$2.15M Sell
6,910
-357
-5% -$105K 0.29% 112
2024
Q4
$1.89M Sell
7,267
-347
-5% -$103K 0.24% 119
2024
Q3
$2.45M Sell
7,614
-369
-5% -$121K 0.31% 102
2024
Q2
$2.49M Sell
7,983
-171
-2% -$50.2K 0.34% 95
2024
Q1
$2.32M Buy
8,154
+741
+10% +$217K 0.32% 99
2023
Q4
$2.14M Sell
7,413
-175
-2% -$47.7K 0.32% 100
2023
Q3
$2.04M Sell
7,588
-542
-7% -$135K 0.34% 100
2023
Q2
$1.81M Sell
8,130
-286
-3% -$66.4K 0.29% 107
2023
Q1
$2.03M Buy
8,416
+423
+5% +$104K 0.34% 91
2022
Q4
$2.1M Buy
7,993
+62
+0.8% +$16.6K 0.37% 85
2022
Q3
$1.79M Buy
7,931
+303
+4% +$73.4K 0.35% 83
2022
Q2
$1.86M Buy
7,628
+966
+15% +$237K 0.35% 79
2022
Q1
$1.61M Sell
6,662
-29
-0.4% -$6.66K 0.27% 103
2021
Q4
$1.5M Sell
6,691
-672
-9% -$142K 0.23% 110
2021
Q3
$1.57M Buy
+7,363
New +$1.69M 0.27% 98
2021
Q2
Sell
-7,112
Closed -$1.77M 126
2021
Q1
$1.77M Buy
7,112
+368
+5% +$87.8K 0.33% 90
2020
Q4
$1.55M Buy
6,744
+248
+4% +$57.2K 0.31% 88
2020
Q3
$1.5M Sell
6,496
-1,377
-17% -$341K 0.33% 86
2020
Q2
$1.88M Buy
7,873
+456
+6% +$104K 0.42% 72
2020
Q1
$1.76M Sell
7,417
-484
-6% -$106K 0.41% 77
2019
Q4
$1.91M Buy
7,901
+216
+3% +$47.6K 0.36% 87
2019
Q3
$1.7M Buy
7,685
+113
+1% +$21.7K 0.33% 92
2019
Q2
$1.33M Buy
7,572
+29
+0.4% +$5.19K 0.26% 101
2019
Q1
$1.33M Sell
7,543
-977
-11% -$187K 0.26% 101
2018
Q4
$1.66M Buy
8,520
+420
+5% +$81.9K 0.36% 94
2018
Q3
$1.68M Buy
8,100
+97
+1% +$19.1K 0.29% 97
2018
Q2
$1.48M Sell
8,003
-1,103
-12% -$195K 0.26% 97
2018
Q1
$1.55M Sell
9,106
-5
-0.1% -$918 0.28% 93
2017
Q4
$1.58M Sell
9,111
-637
-7% -$113K 0.29% 87
2017
Q3
$1.82M Buy
9,748
+80
+0.8% +$14.2K 0.36% 80
2017
Q2
$1.67M Buy
9,668
+214
+2% +$34.8K 0.35% 78
2017
Q1
$1.55M Buy
9,454
+108
+1% +$17.9K 0.34% 82
2016
Q4
$1.37M Buy
9,346
+17
+0.2% +$2.56K 0.33% 78
2016
Q3
$1.56M Buy
9,329
+1,238
+15% +$209K 0.37% 70
2016
Q2
$1.23M Buy
8,091
+2,707
+50% +$421K 0.29% 73
2016
Q1
$807K Buy
5,384
+1,860
+53% +$276K 0.17% 83
2015
Q4
$572K Sell
3,524
-143
-4% -$22.5K 0.12% 104
2015
Q3
$507K Buy
3,667
+52
+1% +$8.2K 0.11% 97
2015
Q2
$555K Sell
3,615
-19
-0.5% -$3.04K 0.13% 98
2015
Q1
$581K Buy
+3,634
New +$572K 0.16% 94

Other funds holding AMGN

Signet Financial Management's AMGN Position: Q1 2026 in Review

Signet Financial Management reduced its Amgen (AMGN) stake by 1.7% in Q1 2026, selling an estimated $37.4K and leaving 6,053 shares worth $2.13M. The position accounts for 0.24% of the portfolio, ranked #115.

Signet Financial Management first reported a position in AMGN in Q1 2015 and has held it in 44 quarters since. The position peaked at $2.49M in Q2 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Signet Financial Management held 6,053 shares of Amgen worth $2.13M as of Q1 2026.
  • Signet Financial Management sold 105 Amgen shares in Q1 2026, an estimated $37.4K.
  • Amgen made up 0.24% of Signet Financial Management's portfolio in Q1 2026, its #115 holding.
  • Signet Financial Management first reported a position in Amgen in Q1 2015 and has held it in 44 quarters since.
  • Signet Financial Management's Amgen position peaked at $2.49M in Q2 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.